Veriheal
MARCH 1, 2022
The first legal psilocybin therapy program to take shape in America is slowly progressing in Oregon. Kate Brown conducts regularly scheduled monthly meetings with a goal of shaping the nation’s first Psilocybin therapy program. Oregon’s Psilocybin Therapy Program: Advisory Board Hard at Work.
Veriheal
AUGUST 4, 2023
What DMT can teach us about dying, ketamine infusion therapy provides hope for fibromyalgia patients, and “Cocaine Shark” steals headlines. Patients considering this cutting-edge therapy will first need to undergo a clinical assessment. Let’s dive into this week’s canna-news.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Canna Law Blog
NOVEMBER 27, 2021
Also, according to the DEA, “the history of human experience probably goes back several hundred years since DMT usage is associated with a number of religious practices and rituals.” is expanding rapidly as numerous neuropharmaceutical companies look to be among the first-to-market potentially revolutionary therapies.
Cannabis Law Report
JUNE 16, 2021
This relationship enables us to initiate our clinical research program and marks an important step for Wake in Canada. We are excited to explore the potential of emergent psychedelic therapies. ABOUT SANTÉ CANNABIS. Santé Cannabis is at the forefront of safe and supported patient access to complementary medicines.
Cannabis Law Report
MAY 19, 2022
“We look at the diagnosis, the medical history, if there’s a risk of addiction, what treatments have already been tried …. Health Canada says it has received 15 requests for the use of psilocybin or MDMA — a psychedelic drug with stimulant properties — since resuming the program. ” Health Canada on Jan.
Veriheal
JUNE 29, 2021
Plant medicines and concoctions made from them have been utilized throughout the history of cultures around the world. In the last 100 years, many of the plant therapies that were embraced in history were outlawed by governments around the world and replaced by lab-made synthetic drugs we label medicine. A Push by Patients.
Veriheal
FEBRUARY 14, 2024
Under the new measure, the Department of Human Services (DHS) will be able to offer licenses to psilocybin therapy centers with trained therapists and psychedelic facilitators. The goal is to ensure that psychedelic therapy remains safe, accessible, and affordable to those 21 and older.
Expert insights. Personalized for you.
98 
Let's personalize your content